OpenEvidence is an AI‑powered company that helps doctors work faster, smarter, and with greater confidence. The platform acts like a “medical evidence engine plus assistant,” turning complex research into clear, practical answers that clinicians can use at the point of care.
OpenEvidence was founded in 2021 by Daniel Nadler and Zachary Ziegler, both with strong backgrounds in data, artificial intelligence, and machine learning. They created the company to solve a problem many doctors face: the flood of new medical studies makes it nearly impossible to stay fully up to date.
The platform reads, organizes, and explains medical evidence in plain language, always linking answers back to real‑world research and clinical sources. This lets doctors quickly check guidelines, compare treatments, and run calculations without getting lost in technical jargon or long papers.
From the start, OpenEvidence has taken a different path from typical health‑tech firms. Instead of focusing on long hospital sales cycles, the founders talk directly to doctors, treating them as busy, intelligent users. This “direct‑to‑doctor” model helps the product spread by word‑of‑mouth, because its real test is whether individual clinicians find it useful every day.
Inside the company, the leadership style is small, flat, and fast. The team is compact but highly specialized, with engineers and researchers who understand both AI and medicine. New features are built quickly, based on feedback from doctors, so the platform keeps evolving to match real‑world needs.
Building real impact in healthcare
OpenEvidence has become one of the most widely used AI tools for doctors in the United States. By 2025, more than 100 million Americans will be treated by physicians who use the platform, showing how deeply it has embedded itself into routine clinical work. The company has also joined forces with major medical publishers, including the NEJM Group and the Journal of the American Medical Association (JAMA) Network.
Technically, it stands out by using specialized medical‑language models trained on real clinical data, not generic AI systems. This focus on accuracy and “no‑hallucination” answers has helped doctors trust the platform when planning treatments, ordering tests, and explaining options to patients.
Making clinical work faster and smoother
For doctors, OpenEvidence works like a smart, always‑on research partner. Instead of hunting through dozens of papers or trying to recall the latest guidelines, clinicians can ask simple questions and get answers in seconds, with clear references. The platform can also draft letters, summarize complex studies, and handle routine calculations, which cuts down on repetitive paperwork and clerical tasks.
Health systems that adopt OpenEvidence often notice improvements in how quickly decisions are made and how consistently evidence‑based practices are used. By bringing scattered research into one easy‑to‑search resource, the company helps projects, from updating protocols to improving patient safety, move forward with fewer delays.
A human‑centered vision for the future
The founders are guided by both personal experience and practical problem-solving. Nadler’s family history with medical errors and Ziegler’s experience with a loved one’s serious illness gave them a strong sense of why clear, fast medical information can change lives. This empathy shows in how they design the product: they care less about flashy AI demos and more about real impact at the bedside.
Going forward, OpenEvidence plans to deepen its role as a “medical intelligence layer” for modern healthcare. Key goals include expanding content partnerships, integrating more closely with clinical workflows, and refining their models so that doctors can spend less time managing information and more time caring for patients.
